<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
November 27, 2000
--------------------------------------------------------------------
(Date of earliest event reported)
Cephalon, Inc.
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-19119 23-2484489
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation or organization) File Number) ID No.)
145 Brandywine Parkway
West Chester, Pennsylvania 19380
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(610) 344-0200
--------------------------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS.
On November 27, 2000, Cephalon, Inc. (the "Registrant") publicly
announced that it has entered into a collaboration agreement with Novartis
Pharma AG to consolidate the sales and marketing efforts of four Novartis CNS
products with the Registrant's PROVIGIL(R) (modafinil) Tablets [C-IV] in the
United Kingdom.
The Registrant hereby incorporates by reference the press release attached
hereto as Exhibit 99.1, and made a part of this Item 5.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) _Financial Statements of Business Acquired:_ None
(b) _Pro Forma Financial Information:_ None
(c) _Exhibits:_ Reference is made to the Exhibit Index annexed hereto
and made a part hereof.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CEPHALON, INC.
Date: November 28, 2000 By: /s/ FRANK BALDINO, JR.
----------------- ------------------------------------
Frank Baldino, Jr.
Chairman and Chief Executive Officer
<PAGE>
EXHIBIT INDEX
EXHIBIT PAGE
99.1 Press Release dated November 27, 2000.
